Primary Climate Goal
This company has not set a company-wide target for an absolute reduction in GHG emissions yet
GHG emissions and Carbon intensity
Scope 1 + 2 GHG emissions (in tons of CO2e) divided by the company's Revenues (in USDm) for the same period
Hikma Pharmaceuticals reported Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 124 Kt (-0.44 /-0.4% y-o-y). Also positively, carbon intensity decreased to 53 t (-3.5 /-6.2% y-o-y).
Hikma Pharmaceuticals reported Scope 3 emissions for the the twelve months ending31 December 2020 at 0.8
The company has not set a company-wide target for an absolute reduction in GHG emissions yet.